A HEV-restricted sulfotransferase is expressed in rheumatoid arthritis synovium and is induced by lymphotoxin-alpha/beta and TNF-alpha in cultured endothelial cells

The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lympho...

Full description

Saved in:
Bibliographic Details
Published inBMC immunology Vol. 6; no. 1; p. 6
Main Authors Pablos, José L, Santiago, Begoña, Tsay, Durwin, Singer, Mark S, Palao, Guillermo, Galindo, María, Rosen, Steven D
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 07.03.2005
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lymphocytes with sulfated glycoprotein ligands on HEV results in lymphocyte rolling, which represents the initial step in lymphocyte homing. HEV expression of GlcNAc6ST-2 (also known as HEC-GlcNAc6ST, GST-3, LSST or CHST4), an HEV-restricted sulfotransferase, is essential for the elaboration of L-selectin functional ligands as well as a critical epitope recognized by MECA-79 mAb. We examined the expression of GlcNAc6ST-2 in relationship to the MECA-79 epitope in rheumatoid arthritis (RA) synovial vessels. Expression of GlcNAc6ST-2 was specific to RA synovial tissues as compared to osteoarthritis synovial tissues and localized to endothelial cells of HEV-like vessels and small flat-walled vessels. Double MECA-79 and GlcNAc6ST-2 staining showed colocalization of the MECA-79 epitope and GlcNAc6ST-2. We further found that both TNF-alpha and lymphotoxin-alphabeta induced GlcNAc6ST-2 mRNA and protein in cultured human umbilical vein endothelial cells. These observations demonstrate that GlcNAc6ST-2 is induced in RA vessels and provide potential cytokine pathways for its induction. GlcNAc6ST-2 is a novel marker of activated vessels within RA ectopic lymphoid aggregates. This enzyme represents a potential therapeutic target for RA.
AbstractList Abstract Background The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lymphocytes with sulfated glycoprotein ligands on HEV results in lymphocyte rolling, which represents the initial step in lymphocyte homing. HEV expression of GlcNAc6ST-2 (also known as HEC-GlcNAc6ST, GST-3, LSST or CHST4), an HEV-restricted sulfotransferase, is essential for the elaboration of L-selectin functional ligands as well as a critical epitope recognized by MECA-79 mAb. Results We examined the expression of GlcNAc6ST-2 in relationship to the MECA-79 epitope in rheumatoid arthritis (RA) synovial vessels. Expression of GlcNAc6ST-2 was specific to RA synovial tissues as compared to osteoarthritis synovial tissues and localized to endothelial cells of HEV-like vessels and small flat-walled vessels. Double MECA-79 and GlcNAc6ST-2 staining showed colocalization of the MECA-79 epitope and GlcNAc6ST-2. We further found that both TNF-α and lymphotoxin-αβ induced GlcNAc6ST-2 mRNA and protein in cultured human umbilical vein endothelial cells. Conclusion These observations demonstrate that GlcNAc6ST-2 is induced in RA vessels and provide potential cytokine pathways for its induction. GlcNAc6ST-2 is a novel marker of activated vessels within RA ectopic lymphoid aggregates. This enzyme represents a potential therapeutic target for RA.
The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lymphocytes with sulfated glycoprotein ligands on HEV results in lymphocyte rolling, which represents the initial step in lymphocyte homing. HEV expression of GlcNAc6ST-2 (also known as HEC-GlcNAc6ST, GST-3, LSST or CHST4), an HEV-restricted sulfotransferase, is essential for the elaboration of L-selectin functional ligands as well as a critical epitope recognized by MECA-79 mAb. We examined the expression of GlcNAc6ST-2 in relationship to the MECA-79 epitope in rheumatoid arthritis (RA) synovial vessels. Expression of GlcNAc6ST-2 was specific to RA synovial tissues as compared to osteoarthritis synovial tissues and localized to endothelial cells of HEV-like vessels and small flat-walled vessels. Double MECA-79 and GlcNAc6ST-2 staining showed colocalization of the MECA-79 epitope and GlcNAc6ST-2. We further found that both TNF-alpha and lymphotoxin-alphabeta induced GlcNAc6ST-2 mRNA and protein in cultured human umbilical vein endothelial cells. These observations demonstrate that GlcNAc6ST-2 is induced in RA vessels and provide potential cytokine pathways for its induction. GlcNAc6ST-2 is a novel marker of activated vessels within RA ectopic lymphoid aggregates. This enzyme represents a potential therapeutic target for RA.
Background: The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lymphocytes with sulfated glycoprotein ligands on HEV results in lymphocyte rolling, which represents the initial step in lymphocyte homing. HEV expression of GlcNAc6ST-2 (also known as HEC-GlcNAc6ST, GST-3, LSST or CHST4), an HEV- restricted sulfotransferase, is essential for the elaboration of L-selectin functional ligands as well as a critical epitope recognized by MECA-79 mAb. Results: We examined the expression of GlcNAc6ST-2 in relationship to the MECA- 79 epitope in rheumatoid arthritis (RA) synovial vessels. Expression of GlcNAc6ST-2 was specific to RA synovial tissues as compared to osteoarthritis synovial tissues and localized to endothelial cells of HEV-like vessels and small flat-walled vessels. Double MECA-79 and GlcNAc6ST-2 staining showed colocalization of the MECA-79 epitope and GlcNAc6ST-2. We further found that both TNF- alpha and lymphotoxin- alpha beta induced GlcNAc6ST-2 mRNA and protein in cultured human umbilical vein endothelial cells. Conclusions: These observations demonstrate that GlcNAc6ST-2 is induced in RA vessels and provide potential cytokine pathways for its induction. GlcNAc6ST-2 is a novel marker of activated vessels within RA ectopic lymphoid aggregates. This enzyme represents a potential therapeutic target for RA.
Abstract Background The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lymphocytes with sulfated glycoprotein ligands on HEV results in lymphocyte rolling, which represents the initial step in lymphocyte homing. HEV expression of GlcNAc6ST-2 (also known as HEC-GlcNAc6ST, GST-3, LSST or CHST4), an HEV-restricted sulfotransferase, is essential for the elaboration of L-selectin functional ligands as well as a critical epitope recognized by MECA-79 mAb. Results We examined the expression of GlcNAc6ST-2 in relationship to the MECA-79 epitope in rheumatoid arthritis (RA) synovial vessels. Expression of GlcNAc6ST-2 was specific to RA synovial tissues as compared to osteoarthritis synovial tissues and localized to endothelial cells of HEV-like vessels and small flat-walled vessels. Double MECA-79 and GlcNAc6ST-2 staining showed colocalization of the MECA-79 epitope and GlcNAc6ST-2. We further found that both TNF-α and lymphotoxin-αβ induced GlcNAc6ST-2 mRNA and protein in cultured human umbilical vein endothelial cells. Conclusion These observations demonstrate that GlcNAc6ST-2 is induced in RA vessels and provide potential cytokine pathways for its induction. GlcNAc6ST-2 is a novel marker of activated vessels within RA ectopic lymphoid aggregates. This enzyme represents a potential therapeutic target for RA.
BACKGROUND: The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive to these organs under physiological conditions, but they can develop in chronically-inflamed tissues. The interaction of L-selectin on lymphocytes with sulfated glycoprotein ligands on HEV results in lymphocyte rolling, which represents the initial step in lymphocyte homing. HEV expression of GlcNAc6ST-2 (also known as HEC-GlcNAc6ST, GST-3, LSST or CHST4), an HEV-restricted sulfotransferase, is essential for the elaboration of L-selectin functional ligands as well as a critical epitope recognized by MECA-79 mAb. RESULTS: We examined the expression of GlcNAc6ST-2 in relationship to the MECA-79 epitope in rheumatoid arthritis (RA) synovial vessels. Expression of GlcNAc6ST-2 was specific to RA synovial tissues as compared to osteoarthritis synovial tissues and localized to endothelial cells of HEV-like vessels and small flat-walled vessels. Double MECA-79 and GlcNAc6ST-2 staining showed colocalization of the MECA-79 epitope and GlcNAc6ST-2. We further found that both TNF-α and lymphotoxin-αβ induced GlcNAc6ST-2 mRNA and protein in cultured human umbilical vein endothelial cells. CONCLUSION: These observations demonstrate that GlcNAc6ST-2 is induced in RA vessels and provide potential cytokine pathways for its induction. GlcNAc6ST-2 is a novel marker of activated vessels within RA ectopic lymphoid aggregates. This enzyme represents a potential therapeutic target for RA.
ArticleNumber 6
Author Galindo, María
Rosen, Steven D
Santiago, Begoña
Pablos, José L
Tsay, Durwin
Singer, Mark S
Palao, Guillermo
AuthorAffiliation 1 Servicio de Reumatología y Unidad de Investigación, Hospital 12 de Octubre, 28041 Madrid, Spain
2 Department of Anatomy, University of California, San Francisco, California, USA
AuthorAffiliation_xml – name: 2 Department of Anatomy, University of California, San Francisco, California, USA
– name: 1 Servicio de Reumatología y Unidad de Investigación, Hospital 12 de Octubre, 28041 Madrid, Spain
Author_xml – sequence: 1
  givenname: José L
  surname: Pablos
  fullname: Pablos, José L
  email: jlpablos@h12o.es
  organization: Servicio de Reumatología y Unidad de Investigación, Hospital 12 de Octubre, 28041 Madrid, Spain. jlpablos@h12o.es
– sequence: 2
  givenname: Begoña
  surname: Santiago
  fullname: Santiago, Begoña
– sequence: 3
  givenname: Durwin
  surname: Tsay
  fullname: Tsay, Durwin
– sequence: 4
  givenname: Mark S
  surname: Singer
  fullname: Singer, Mark S
– sequence: 5
  givenname: Guillermo
  surname: Palao
  fullname: Palao, Guillermo
– sequence: 6
  givenname: María
  surname: Galindo
  fullname: Galindo, María
– sequence: 7
  givenname: Steven D
  surname: Rosen
  fullname: Rosen, Steven D
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15752429$$D View this record in MEDLINE/PubMed
BookMark eNp1kstu1TAQhiNURC-wZIuyYhcaJ46dbBBV1dJKFWwKW8uXcePKsQ-2U_W8Dw-K0xyVHiFWtmf--Ty34-LAeQdF8R7VnxDqySnCFFUNok1FKvKqOHp-H7y4HxbHMd7XNaJ9078pDlFHuwY3w1Hx-6y8uvhZBYgpGJlAlXG22qfAXdQQeITSxBIeN1kRs9e4MowwTzx5o0oe0hhMyoq4df7BzFPJnVoijFOzzHqxLe122ow--UfjKm43Iz8VkPiT8Pbb5WpauHK2aQ45BpzyaQRruC0lWBvfFq81txHe7c6T4sflxe35VXXz_ev1-dlNJbp2SBV0QvEOgyC47bGWSGgtuGhAI4opxaJvFAipWioHpTSlGjgmPR1IP2CVg06K65WrPL9nm2AmHrbMc8OeDD7csVyxkRZYh0iHOt5L3GKMFBWABtJiISjBtaBDZn1eWZtZTKAkuNxTuwfd9zgzsjv_wFBNh77tM-DLChDG_wew75F-YsvE2TJxRhjJiI-7HIL_NecRs8nEpaPcgZ8jy-vQYtIuyVarUAYfYwD9_A2q2bJm_4A_vCzur3q3V-0fa_7VOQ
CitedBy_id crossref_primary_10_1007_s00281_012_0302_3
crossref_primary_10_1097_MOG_0b013e3282f4906d
crossref_primary_10_1099_vir_0_83032_0
crossref_primary_10_1186_s12951_021_00793_9
crossref_primary_10_4049_jimmunol_180_5_3467
crossref_primary_10_1016_j_it_2006_10_007
crossref_primary_10_4049_jimmunol_1701269
crossref_primary_10_1111_j_1600_065X_2009_00786_x
crossref_primary_10_1002_art_22020
crossref_primary_10_3899_jrheum_100263
crossref_primary_10_1095_biolreprod_113_113654
crossref_primary_10_1248_bpb_32_774
crossref_primary_10_1093_glycob_cwp004
crossref_primary_10_1111_j_2047_2927_2014_00192_x
crossref_primary_10_1016_j_cyto_2007_07_184
crossref_primary_10_1111_j_0105_2896_2009_00861_x
crossref_primary_10_1093_humrep_dep247
crossref_primary_10_1002_art_37927
crossref_primary_10_3389_fimmu_2017_00045
crossref_primary_10_1038_s41551_021_00766_1
crossref_primary_10_1371_journal_pone_0091850
crossref_primary_10_3390_cells11162513
crossref_primary_10_3390_ijms25042270
crossref_primary_10_1186_1471_2172_7_12
crossref_primary_10_1371_journal_pone_0116295
crossref_primary_10_1042_BJ20100360
crossref_primary_10_1016_j_smim_2007_12_004
crossref_primary_10_3389_fneur_2022_828970
crossref_primary_10_1042_BJ20070958
crossref_primary_10_1369_0022155417753363
crossref_primary_10_1080_2162402X_2015_1008791
crossref_primary_10_1007_s10456_021_09792_8
crossref_primary_10_1016_j_clindermatol_2007_11_002
crossref_primary_10_1158_0008_5472_CAN_12_1912
crossref_primary_10_1038_ni1330
crossref_primary_10_1242_bio_021600
crossref_primary_10_1016_j_it_2022_07_002
crossref_primary_10_1111_j_1749_6632_2011_06356_x
crossref_primary_10_1186_1477_7827_10_46
crossref_primary_10_1016_j_bbrc_2010_12_110
crossref_primary_10_1074_jbc_M112_363119
crossref_primary_10_1302_2046_3758_112_BJR_2021_0270_R1
crossref_primary_10_1016_j_ajpath_2010_11_009
crossref_primary_10_1073_pnas_0700334104
crossref_primary_10_1016_j_jdermsci_2009_10_001
crossref_primary_10_1093_cvr_cvt263
crossref_primary_10_1586_1744666X_4_2_173
crossref_primary_10_1080_08916930601061470
crossref_primary_10_3389_fimmu_2022_1009306
crossref_primary_10_1074_mcp_M113_028878
crossref_primary_10_1111_pin_12294
crossref_primary_10_1016_j_autrev_2015_06_006
crossref_primary_10_1007_s00011_016_0915_4
crossref_primary_10_1161_CIRCRESAHA_114_301137
Cites_doi 10.1172/JCI119389
10.1083/jcb.107.5.1853
10.1084/jem.20021761
10.1016/S1074-7613(00)80083-7
10.1093/intimm/dxh128
10.1074/jbc.M109958200
10.1038/nature01661
10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0
10.1002/art.20356
10.1146/annurev.immunol.21.090501.080131
10.4049/jimmunol.166.1.650
10.1016/S0002-9440(10)63722-4
10.1016/S1074-7613(01)00188-1
10.4049/jimmunol.166.7.4650
10.1186/ar751
10.1002/1529-0131(199812)41:12<2211::AID-ART17>3.0.CO;2-O
10.1182/blood.V88.9.3259.bloodjournal8893259
10.1007/BF02786481
10.4049/jimmunol.167.2.1072
10.1111/j.1749-6632.2003.tb06042.x
10.1073/pnas.0407503101
10.1016/S0092-8674(01)00394-4
10.1681/ASN.V11122358
10.1016/S0002-9440(10)62313-9
10.4049/jimmunol.170.4.2147
10.1074/jbc.M311150200
10.1038/nri1222
10.1165/ajrcmb.23.4.4113
10.1084/jem.183.4.1461
10.1016/S0002-9440(10)61114-5
10.4049/jimmunol.169.1.424
10.1016/S0002-9440(10)64210-1
10.4049/jimmunol.170.9.4638
10.1073/pnas.93.1.221
10.1084/jem.20030057
10.1084/jem.182.4.1133
10.1016/S1074-7613(00)80199-5
10.1038/nri1054
10.1074/jbc.M404456200
10.4049/jimmunol.173.10.6161
10.1242/jcs.00662
10.1126/science.282.5390.941
10.1002/art.1780261203
10.1083/jcb.145.4.899
10.1056/NEJMoa032534
ContentType Journal Article
Copyright Copyright © 2005 Pablos et al; licensee BioMed Central Ltd.
Copyright_xml – notice: Copyright © 2005 Pablos et al; licensee BioMed Central Ltd.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
H94
5PM
DOA
DOI 10.1186/1471-2172-6-6
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList CrossRef
MEDLINE
AIDS and Cancer Research Abstracts


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1471-2172
EndPage 6
ExternalDocumentID oai_doaj_org_article_516515a8c43441d7be19634bb7640b79
oai_biomedcentral_com_1471_2172_6_6
10_1186_1471_2172_6_6
15752429
Genre Research Support, U.S. Gov't, P.H.S
Comparative Study
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: R37 GM023547
– fundername: NIGMS NIH HHS
  grantid: R37GM23547
– fundername: NIGMS NIH HHS
  grantid: R01GM57411
– fundername: NIGMS NIH HHS
  grantid: R01 GM057411
GroupedDBID ---
-A0
0R~
123
23N
2VQ
2WC
4.4
53G
5VS
6J9
AAFWJ
AAJSJ
ABDBF
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFPKN
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BFQNJ
BMC
C1A
C24
C6C
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
ESX
F5P
GROUPED_DOAJ
GX1
H13
HYE
IAO
IHR
INR
IPNFZ
KQ8
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
RBZ
RIG
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
W2D
WOQ
WOW
XSB
AAYXX
CITATION
7T5
H94
ABVAZ
AFGXO
AFNRJ
ITC
5PM
ID FETCH-LOGICAL-b539t-e5bda54eb64384fc1bffbab2ef174774b82debcd37c9ddf77fea468796894d643
IEDL.DBID RBZ
ISSN 1471-2172
IngestDate Tue Oct 22 15:13:36 EDT 2024
Tue Sep 17 20:55:16 EDT 2024
Wed May 22 07:12:25 EDT 2024
Fri Oct 25 03:42:39 EDT 2024
Thu Sep 26 15:42:25 EDT 2024
Sat Nov 02 12:30:57 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b539t-e5bda54eb64384fc1bffbab2ef174774b82debcd37c9ddf77fea468796894d643
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink http://dx.doi.org/10.1186/1471-2172-6-6
PMID 15752429
PQID 17834639
PQPubID 23462
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_516515a8c43441d7be19634bb7640b79
pubmedcentral_primary_oai_pubmedcentral_nih_gov_1079838
biomedcentral_primary_oai_biomedcentral_com_1471_2172_6_6
proquest_miscellaneous_17834639
crossref_primary_10_1186_1471_2172_6_6
pubmed_primary_15752429
PublicationCentury 2000
PublicationDate 2005-03-07
PublicationDateYYYYMMDD 2005-03-07
PublicationDate_xml – month: 03
  year: 2005
  text: 2005-03-07
  day: 07
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC immunology
PublicationTitleAlternate BMC Immunol
PublicationYear 2005
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References N Hiraoka (67_CR20) 2004; 279
M Salmi (67_CR23) 2001; 166
A Braun (67_CR47) 2004; 50
NM Carter (67_CR46) 2003; 116
A van Zante (67_CR19) 2003; 198
CM Weyand (67_CR4) 2003; 987
M Salmi (67_CR24) 1997; 99
K Shi (67_CR38) 2001; 166
UH von Andrian (67_CR8) 2003; 3
N Hiraoka (67_CR12) 1999; 11
SA Michie (67_CR25) 1993; 143
JC Yeh (67_CR13) 2001; 105
DL Drayton (67_CR28) 2003; 197
S Toppila (67_CR30) 2000; 23
AE Schroder (67_CR2) 1996; 93
JP Turunen (67_CR31) 1995; 182
K Uchimura (67_CR14) 2004; 279
J Kirveskari (67_CR32) 2000; 11
CC Reparon-Schuijt (67_CR35) 2001; 44
U Samulowitz (67_CR15) 2002; 160
A Maiti (67_CR45) 1998; 282
SA Luther (67_CR42) 2000; 12
NH Ruddle (67_CR6) 1999; 19
P Delmotte (67_CR44) 2002; 277
A Kratz (67_CR5) 1996; 183
M Kobayashi (67_CR29) 2004; 101
CC Reparon-Schuijt (67_CR36) 1998; 41
PR Streeter (67_CR17) 1988; 107
JC Edwards (67_CR37) 2004; 350
S Hemmerich (67_CR18) 2001; 15
SA Luther (67_CR41) 2002; 169
A Bistrup (67_CR11) 1999; 145
JL Pablos (67_CR40) 2003; 170
H Kanda (67_CR16) 2004; 16
RE Mebius (67_CR7) 2003; 3
SD Rosen (67_CR9) 2004; 22
DL Drayton (67_CR43) 2004; 173
A Bistrup (67_CR26) 2004; 164
AJ Freemont (67_CR22) 1983; 26
GS Kansas (67_CR10) 1996; 88
67_CR27
JJ Goronzy (67_CR34) 2003; 5
GS Firestein (67_CR1) 2003; 423
S Takemura (67_CR3) 2001; 167
J Renkonen (67_CR21) 2002; 161
SD Rosen (67_CR33) 2005; 166
W Weninger (67_CR39) 2003; 170
References_xml – volume: 99
  start-page: 2165
  year: 1997
  ident: 67_CR24
  publication-title: J Clin Invest
  doi: 10.1172/JCI119389
  contributor:
    fullname: M Salmi
– volume: 107
  start-page: 1853
  year: 1988
  ident: 67_CR17
  publication-title: J Cell Biol
  doi: 10.1083/jcb.107.5.1853
  contributor:
    fullname: PR Streeter
– volume: 197
  start-page: 1153
  year: 2003
  ident: 67_CR28
  publication-title: J Exp Med
  doi: 10.1084/jem.20021761
  contributor:
    fullname: DL Drayton
– volume: 11
  start-page: 79
  year: 1999
  ident: 67_CR12
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80083-7
  contributor:
    fullname: N Hiraoka
– volume: 16
  start-page: 1265
  year: 2004
  ident: 67_CR16
  publication-title: Int Immunol
  doi: 10.1093/intimm/dxh128
  contributor:
    fullname: H Kanda
– volume: 277
  start-page: 424
  year: 2002
  ident: 67_CR44
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109958200
  contributor:
    fullname: P Delmotte
– volume: 423
  start-page: 356
  year: 2003
  ident: 67_CR1
  publication-title: Nature
  doi: 10.1038/nature01661
  contributor:
    fullname: GS Firestein
– volume: 44
  start-page: 41
  year: 2001
  ident: 67_CR35
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0
  contributor:
    fullname: CC Reparon-Schuijt
– volume: 50
  start-page: 2140
  year: 2004
  ident: 67_CR47
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20356
  contributor:
    fullname: A Braun
– volume: 22
  start-page: 129
  year: 2004
  ident: 67_CR9
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.21.090501.080131
  contributor:
    fullname: SD Rosen
– volume: 166
  start-page: 650
  year: 2001
  ident: 67_CR38
  publication-title: J Immunol
  doi: 10.4049/jimmunol.166.1.650
  contributor:
    fullname: K Shi
– volume: 164
  start-page: 1635
  year: 2004
  ident: 67_CR26
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)63722-4
  contributor:
    fullname: A Bistrup
– volume: 15
  start-page: 237
  year: 2001
  ident: 67_CR18
  publication-title: Immunity
  doi: 10.1016/S1074-7613(01)00188-1
  contributor:
    fullname: S Hemmerich
– volume: 166
  start-page: 4650
  year: 2001
  ident: 67_CR23
  publication-title: J Immunol
  doi: 10.4049/jimmunol.166.7.4650
  contributor:
    fullname: M Salmi
– volume: 5
  start-page: 131
  year: 2003
  ident: 67_CR34
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar751
  contributor:
    fullname: JJ Goronzy
– volume: 41
  start-page: 2211
  year: 1998
  ident: 67_CR36
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(199812)41:12<2211::AID-ART17>3.0.CO;2-O
  contributor:
    fullname: CC Reparon-Schuijt
– volume: 88
  start-page: 3259
  year: 1996
  ident: 67_CR10
  publication-title: Blood
  doi: 10.1182/blood.V88.9.3259.bloodjournal8893259
  contributor:
    fullname: GS Kansas
– volume: 19
  start-page: 119
  year: 1999
  ident: 67_CR6
  publication-title: Immunol Res
  doi: 10.1007/BF02786481
  contributor:
    fullname: NH Ruddle
– volume: 167
  start-page: 1072
  year: 2001
  ident: 67_CR3
  publication-title: J Immunol
  doi: 10.4049/jimmunol.167.2.1072
  contributor:
    fullname: S Takemura
– volume: 987
  start-page: 140
  year: 2003
  ident: 67_CR4
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2003.tb06042.x
  contributor:
    fullname: CM Weyand
– volume: 143
  start-page: 1688
  year: 1993
  ident: 67_CR25
  publication-title: Am J Pathol
  contributor:
    fullname: SA Michie
– volume: 101
  start-page: 17807
  year: 2004
  ident: 67_CR29
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0407503101
  contributor:
    fullname: M Kobayashi
– volume: 105
  start-page: 957
  year: 2001
  ident: 67_CR13
  publication-title: Cell
  doi: 10.1016/S0092-8674(01)00394-4
  contributor:
    fullname: JC Yeh
– volume: 11
  start-page: 2358
  year: 2000
  ident: 67_CR32
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V11122358
  contributor:
    fullname: J Kirveskari
– volume: 166
  start-page: 935
  year: 2005
  ident: 67_CR33
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)62313-9
  contributor:
    fullname: SD Rosen
– volume: 170
  start-page: 2147
  year: 2003
  ident: 67_CR40
  publication-title: J Immunol
  doi: 10.4049/jimmunol.170.4.2147
  contributor:
    fullname: JL Pablos
– volume: 279
  start-page: 3058
  year: 2004
  ident: 67_CR20
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M311150200
  contributor:
    fullname: N Hiraoka
– volume: 3
  start-page: 867
  year: 2003
  ident: 67_CR8
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1222
  contributor:
    fullname: UH von Andrian
– volume: 23
  start-page: 492
  year: 2000
  ident: 67_CR30
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/ajrcmb.23.4.4113
  contributor:
    fullname: S Toppila
– volume: 183
  start-page: 1461
  year: 1996
  ident: 67_CR5
  publication-title: J Exp Med
  doi: 10.1084/jem.183.4.1461
  contributor:
    fullname: A Kratz
– volume: 160
  start-page: 1669
  year: 2002
  ident: 67_CR15
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)61114-5
  contributor:
    fullname: U Samulowitz
– volume: 169
  start-page: 424
  year: 2002
  ident: 67_CR41
  publication-title: J Immunol
  doi: 10.4049/jimmunol.169.1.424
  contributor:
    fullname: SA Luther
– volume: 161
  start-page: 543
  year: 2002
  ident: 67_CR21
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)64210-1
  contributor:
    fullname: J Renkonen
– ident: 67_CR27
– volume: 170
  start-page: 4638
  year: 2003
  ident: 67_CR39
  publication-title: J Immunol
  doi: 10.4049/jimmunol.170.9.4638
  contributor:
    fullname: W Weninger
– volume: 93
  start-page: 221
  year: 1996
  ident: 67_CR2
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.93.1.221
  contributor:
    fullname: AE Schroder
– volume: 198
  start-page: 1289
  year: 2003
  ident: 67_CR19
  publication-title: J Exp Med
  doi: 10.1084/jem.20030057
  contributor:
    fullname: A van Zante
– volume: 182
  start-page: 1133
  year: 1995
  ident: 67_CR31
  publication-title: J Exp Med
  doi: 10.1084/jem.182.4.1133
  contributor:
    fullname: JP Turunen
– volume: 12
  start-page: 471
  year: 2000
  ident: 67_CR42
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80199-5
  contributor:
    fullname: SA Luther
– volume: 3
  start-page: 292
  year: 2003
  ident: 67_CR7
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1054
  contributor:
    fullname: RE Mebius
– volume: 279
  start-page: 35001
  year: 2004
  ident: 67_CR14
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M404456200
  contributor:
    fullname: K Uchimura
– volume: 173
  start-page: 6161
  year: 2004
  ident: 67_CR43
  publication-title: J Immunol
  doi: 10.4049/jimmunol.173.10.6161
  contributor:
    fullname: DL Drayton
– volume: 116
  start-page: 3591
  year: 2003
  ident: 67_CR46
  publication-title: J Cell Sci
  doi: 10.1242/jcs.00662
  contributor:
    fullname: NM Carter
– volume: 282
  start-page: 941
  year: 1998
  ident: 67_CR45
  publication-title: Science
  doi: 10.1126/science.282.5390.941
  contributor:
    fullname: A Maiti
– volume: 26
  start-page: 1427
  year: 1983
  ident: 67_CR22
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780261203
  contributor:
    fullname: AJ Freemont
– volume: 145
  start-page: 899
  year: 1999
  ident: 67_CR11
  publication-title: J Cell Biol
  doi: 10.1083/jcb.145.4.899
  contributor:
    fullname: A Bistrup
– volume: 350
  start-page: 2572
  year: 2004
  ident: 67_CR37
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa032534
  contributor:
    fullname: JC Edwards
SSID ssj0017828
Score 1.9988762
Snippet The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV are exclusive...
Abstract Background The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules...
Background: The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV...
BACKGROUND: The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules (HEV). HEV...
Abstract Background The recruitment of lymphocytes to secondary lymphoid organs relies on interactions of circulating cells with high endothelial venules...
SourceID doaj
pubmedcentral
biomedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 6
SubjectTerms Antigens, Surface - biosynthesis
Antigens, Surface - genetics
Arthritis, Rheumatoid - enzymology
Arthritis, Rheumatoid - pathology
Carbohydrate Sulfotransferases
Cells, Cultured - drug effects
Cells, Cultured - metabolism
Chemotaxis, Leukocyte - physiology
Endothelial Cells - drug effects
Endothelial Cells - metabolism
Endothelium, Vascular - cytology
Humans
L-Selectin - physiology
Lymphotoxin-alpha - pharmacology
Lymphotoxin-beta
Membrane Proteins - biosynthesis
Membrane Proteins - genetics
Membrane Proteins - pharmacology
Receptors, Lymphocyte Homing - physiology
Sulfotransferases - biosynthesis
Sulfotransferases - genetics
Synovial Membrane - metabolism
Synovial Membrane - pathology
Tumor Necrosis Factor-alpha - pharmacology
Venules - cytology
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQpSIuiJa_hQI-IG7WdhPHP8cWdbVCak8t6s2yY1sbaXGqTYK678JLwIP0mRg72dKskLhw3NiOvJ7PmW9kzzcIfcwLBm7BW-KyTBLKHCXaSU1MlnFWCi5YSgo7v2CLK_rlurh-UOor3gnr5YH7hZsWs1isW4uS5uC5LTcuYoYawxk9NrxP3TuW22BqOD8Av5eS4ODTS2IJpq26pmDT-2eEEbaT5r4aeack4v835rl7gfKBR5o_Q08HKolP-r9wgB65cIj2--KSm0P0-Hw4Nn-OfpzgxdlXEstwwGcPOCZuupWv20Ra3RocGa4a7G7TpVhorQJeL10HZLauLIY1WibpI9xsQv296r5hHWwcAfE8IMNis8GrDcCibuvbKpC7n9O7X6nP5cUcfsX39Qof0NcFG5O-VoB7HE8Nmhfoan52-XlBhrIMxBS5bIkrjNUFdQbIjKC-nBnvjTaZ8xDdAJs0IrPOlDbnpbTWc-6dpkxwyYSkFga9RHuhDu41wlxrnxXGM2YsxOlWeg2UUBpuSj_LCztBcmQeddNLcKgoij1ugf2pomlVNK1iik3Qp60p74eliEew3Y6n0dCjd6cHAEM1wFD9C4YT9GELEwUbNK6fDq7uGjWLpUyAB07Qqx40f2YDVBkYErTwEZxGMxm3hGqZJMAhaJciF2_-x9TfoidJjzZerONHaK9dd-4dMK3WvE-b6jeWHysS
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: PubMed Central
  dbid: RPM
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLXaSiA2CMqjU15eIHbuMInjx7JUHY2QpmLRou4iO7aZSBmnmmRQ51_6E_Ah_SauPQmQESuWiR-yfI99z5XvA6H3acZALThDbJJIQpmlRFmpiE4SzgrBBYtBYfMLNruin6-z6z2U9bEw0Wm_0OWJr5YnvlxE38qbZTHu_cTGX-ZnYLJIkYrxPtoHgPYmevd0ACpP9Mk0BRtP4PYloQoTYSTWKwJ-AmpJ7gS4VwO9FNP3_4tz7rpO_qWLpk_Q445E4tPtYp-iPesP0YNtWcnNIXo47x7Mn6G7Uzw7_0pCAQ648IBd4mZdubqNdNWuQIXhssH2NrrDQmvp8Wph10Bj69Jg2I1FTHqEm42vv5frJVbehBFgyQMmDNYbXG0AEHVb35ae3P8Y3_-MfS4vpvAV5tvm9oC-1psQ7lUB4nF4L2ieo6vp-eXZjHQFGYjOUtkSm2mjMmo10BhBXTHRzmmlE-vArgEeqUVirC5MygtpjOPcWUWZ4JIJSQ0MeoEOfO3tEcJcKZdk2jGmDVjoRjoFZFBqrgs3STMzQnIgnvxmm3wjD-mwhy1wMvMg5TxIOWc5G6EPvSh_D4u2jmC7HT8FQQ_mjj_q1be8A1yeTUK1eCUKmgJ1NFzbcGlRrTmjHzWXI_Suh0kORzPsn_K2Xjf5JBQxAQY4Qi-3oPmzmg6EI8QHcBqsZNgCZyEm_-6wf_zfI1-hRzH9bPCj46_RQbta2zdArFr9Nh6kX62jKx8
  priority: 500
  providerName: National Library of Medicine
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagCMQFQXktTx8QN1OSOH4cECqoqxVSe-qi3iI7ttlIIYFkgzb_hT8BP6S_ibGTZcmqN46JH7I8M55v5PE3CL1KUgZuwRli41gSyiwlykpFdBxzlgsuWHgUdnrGFkv66SK92FEKjRvYXhna-XpSy6Z8s_nevweDfxcMXrCjCA5Y4gstEUbYdXQjphCk-yw-urtQAEcYXsVtu27pNveH7717LyfuKrD6XwVF9zMq_3FR87vozogt8fGgDPfQNVsdoptDtcn-EN06He_R76Ofx3hx8pn4uhxwDgLoxG1XunodUKxtwLPhosV2E7JkobWocLOyHaDbujAYtG0VuJBw21f1j6L7ilVl_AgI8EFVDNY9LnvQk3pdb4qKXP46uvwd-pyfzeHLzzdQfkBfWxn_CqwEQ8D-GqF9gJbzk_OPCzLWaSA6TeSa2FQblVKrAd0I6vJIO6eVjq2DcAfgpRaxsTo3Cc-lMY5zZxVlgksmJDUw6CE6qOrKPkaYK-XiVDvGtIHA3UinACNKzXXuoiQ1MyQn4sm-DZwcmWfJnraAwWZetJkXbcYyNkOvt6L8OyyEQILtd_zgBT2ZO_yomy_ZaNBZGvki8krkNAFEabi2_iyjWnNG32ouZ-jlVk0ysFi_f6qydddmka9tAsBwhh4NSrNbDWBngEzQwifqNFnJtKUqVoETHKJ4KRLx5D_25ym6HXhpfYIdf4YO1k1nnwPiWusXwZb-AD2LMW4
  priority: 102
  providerName: Scholars Portal
Title A HEV-restricted sulfotransferase is expressed in rheumatoid arthritis synovium and is induced by lymphotoxin-alpha/beta and TNF-alpha in cultured endothelial cells
URI https://www.ncbi.nlm.nih.gov/pubmed/15752429
https://search.proquest.com/docview/17834639
http://dx.doi.org/10.1186/1471-2172-6-6
https://pubmed.ncbi.nlm.nih.gov/PMC1079838
https://doaj.org/article/516515a8c43441d7be19634bb7640b79
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagFYgLgvJaHosPiJtVkjh-HLeoq9VK2wstqrhYdmxrI20TtElQ97_wJ-CH9DcxdnZbsuLGJVIydmR5xp5v_PgGoQ9ZzsAteEtcmkpCmaNEO6mJSVPOCsEFi5fCFmdsdkHnl_nlHUnS3g5-IthxAtMnCWmUCCPsPjpMA59KCMtPvt1uF4Cbi3fedkV3ZJr71fduta8Gzihy9v8LaO6fl_zLAU2foMdb5IgnvaqfonuuOkIP-lySmyP0cLHdJX-Gfk7w7PQrCVk3YJYDSImbbuXrNmJUtwa_hcsGu-t4BhakZYXXS9cBdq1Li8GWlpHpCDebqv5RdldYVzbUgPAdDMFis8GrDVhB3dbXZUVufh3f_I5lzs-m8Bb-1xN6QFlX2XDHawVmjsMmQfMcXUxPzz_PyDYLAzF5JlvicmN1Tp0B7CKoLxLjvdEmdR6CGQCPRqTWmcJmvJDWes6905QJLpmQ1EKlF-igqiv3CmGutU9z4xkzFsJyK70GBCgNN4VPstyOkByoR33vGTdU4MAeSmA4qqBaFVSrmGIj9HGnyttqMcARbL_gSVD04N_xAxid2g5XlSchRbwWBc0AL1puXJipqDGc0U-GyxF6vzMTBeMx9J-uXN01KgmZSwD2jdDL3mjuWgPIGAARSPjAnAYtGUqqchkZvyFGlyITr_-jf96gR5F1Nhyf42_RQbvu3DvAU60Zo8PJZP5lPo7rEfBcUDGO42scF7_-AIMBKFk
link.rule.ids 108,230,315,730,783,787,867,888,2109,2228,24330,24949,27936,27937,53804,53806,76140,76141
linkProvider BioMedCentral
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKEY8LgvJaXvUBcTNlE8ePY4u6WqC7B7RFFRfLjm020jZBmyzq_hf-BPyQ_ibGzqY0K24cE3siy_P6JvbMIPQ6zRi4BW-JSxJJKHOUaCc1MUnCWS64YDEpbDJl41P68Sw720GjLhfGnOdFSIyI_5TfXk9BX0S73V0Xa7VdsIMhWFcSuiwRRtgNdBPCchoU9PPR16vTBPCCMSWum9rV2twm30p6X_R8VSzp_y8cun2d8pp_Gt1H9zbAEh-2K3-Adly5h261rSbXe-j2ZHOI_hD9PMTj4y8kNOUAIwiIE9erha-aCGHdEtwaLmrsLuIVWRgtSrycuxVA26qwGLZmHgsh4XpdVj-K1TnWpQ0UEN2DnFhs1nixBiGpmuqiKMnlr4PL33HObDqCp_C9tt4HzHWlDSlgC9ACHM4Q6kfodHQ8ez8mmyYNxGSpbIjLjNUZdQagjaA-HxrvjTaJ8xDrALY0IrHO5DblubTWc-6dpkxwyYSkFogeo92yKt1ThLnWPsmMZ8xYiNqt9BoAojTc5H6YZnaAZI896ntbkEOFEtn9ERAVFVirAmsVU2yA3nSsvCKL8Y9g2xOPAqN7344vquU3tZE-lQ1DB3ktcpoCnLTcuGDIqDGc0XeGywHa78REgbqG_dOlq1a1GobGJoAKB-hJKzR_VwPAGfASjPCeOPVW0h8pi3ksCA4hvBSpePYf-7OP7oxnkxN18mH66Tm6GwvUhpt2_AXabZYr9xKgV2NeRb36AxSGM6E
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKERUXBOW15VEfEDezbOL4cWyhy_LoCqEWVVwsO7bZqGlS7QN1_wt_An5IfxNjZ1OaFTduSca2LM-M55vYM4PQizRjYBa8JS5JJKHMUaKd1MQkCWe54ILFoLDDMRsd0w8n2ckGetfGwpizvAiBEfGf8qvrIehl3LfhIT_tn1vfqLtg_QFsrySUWSKMsBvoJvjlNNRw-LL_7eo4AcxgjIlrm7bJNte7r0W9lx1jFXP6_wuIrt-nvGaghnfRnRWyxHuNKNxDG67aRreaWpPLbbR1uDpFv49-7uHRwVcSqnLALgiQE88Wpa_nEcO6Kdg1XMywu4h3ZIFaVHg6cQvAtnVhMcjaJGZCwrNlVf8oFmdYVzb0APceBMVis8TlEqSkntcXRUUuf_Uvf8c2R-MhvIXxmoQf0NZVNsSAlaAGOBwizB6g4-HB0ZsRWVVpICZL5Zy4zFidUWcA2wjq84Hx3miTOA_ODoBLIxLrTG5TnktrPefeacoEl0xIaqHTQ7RZ1ZV7jDDX2ieZ8YwZC267lV4DQpSGm9wP0sz2kOywR503GTlUyJHdpYCsqMBaFVirmGI99LJl5VW36AAJtt5wPzC6M3b8UE-_q5U6q2wQSshrkdMU8KTlxoWdjBrDGX1tuOyh3VZMFOhrWD9duXoxU4NQ2QRgYQ89aoTm72wAOQNgAgrviFNnJl1KVUxiRnDw4aVIxc5_rM8u2vr8dqg-vR9_fIJuxwS14aYdf4o259OFewbQa26eR7X6A4IwM2w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+HEV-restricted+sulfotransferase+is+expressed+in+rheumatoid+arthritis+synovium+and+is+induced+by+lymphotoxin-%CE%B1%2F%CE%B2+and+TNF-%CE%B1+in+cultured+endothelial+cells&rft.jtitle=BMC+immunology&rft.au=Pablos%2C+Jos%C3%A9&rft.au=Santiago%2C+Bego%C3%B1a&rft.au=Tsay%2C+Durwin&rft.au=Singer%2C+Mark&rft.date=2005-03-07&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2172&rft.eissn=1471-2172&rft.volume=6&rft.issue=1&rft.spage=6&rft.epage=6&rft_id=info:doi/10.1186%2F1471-2172-6-6&rft.externalDBID=n%2Fa&rft.externalDocID=oai_biomedcentral_com_1471_2172_6_6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2172&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2172&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2172&client=summon